ArticleCell reports. Medicine2025

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.

Madelaine S Theardy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.